Aspire Biopharma Holdings (ASBP) EBT (2024 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly EBT came in at -$3.2 million in Q1 2026, up 79.78% year-on-year from -$1.8 million in Q1 2025, and up 60.13% on a QoQ basis from -$8.1 million in Q4 2025.
Aspire Biopharma Holdings (ASBP) EBT (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of EBT data on file, last reported at -$3.2 million in Q1 2026.
- On a quarterly basis, EBT rose 79.78% year-over-year to -$3.2 million in Q1 2026; TTM through Mar 2026 was -$29.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$24.5 million, down 1770.4% from the prior year.
- EBT for Q1 2026 stood at -$3.2 million, up from -$8.1 million in the prior quarter.
- Over the last five years, EBT for ASBP reached as high as -$215256.0 in Q3 2024 and fell as low as -$15.9 million in Q1 2025.
- Historically, EBT has averaged -$5.1 million across 3 years, with a median of -$2.9 million in 2025.
- Across the five-year window, EBT plunged 1257.0% in 2025 and soared 79.78% in 2026, its largest moves.
- Year by year, EBT stood at -$595639.0 in 2024, then plunged by 1257.0% to -$8.1 million in 2025, then soared by 60.13% to -$3.2 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$3.2 million in Q1 2026, -$8.1 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | -3.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.22 Mn |
| Dec 31, 2025 | -8.08 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Mar 31, 2025 | -15.94 Mn |
| Dec 31, 2024 | -595,639.00 |
| Sep 30, 2024 | -215,256.00 |